Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study - 13/01/18
Doi : 10.1016/j.jaad.2017.07.053
Amrita Goyal, MD a, b, c, Joi B. Carter, MD b, d, Itai Pashtan, MD e, Sara Gallotto, MS a, Irene Wang, BA a, Scott Isom, MS f, Andrea Ng, MD e, Karen M. Winkfield, MD, PhD a, f, ⁎ 
a Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
e Department of Radiation Oncology, Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts
c Department of Dermatology, University of Minnesota, Minneapolis, Minnesota
d Section of Dermatology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
f Department of Radiation Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina
∗Reprint requests: Karen M. Winkfield, MD, PhD, Department of Radiation Oncology, Wake Forest Baptist Health, 1 Medical Center Blvd, Winston-Salem, NC 27157Department of Radiation OncologyWake Forest Baptist Health1 Medical Center BlvdWinston-SalemNC27157
| Statistical analysis (by Mr Isom) supported by the Wake Forest Baptist Comprehensive Cancer Center's National Cancer Institute Cancer Center Support Grant P30CA012197. |
|
| Conflicts of interest: None declared. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 2
P. 408-410 - février 2018 Retour au numéro
Article précédent
- Socioeconomic and geographic barriers to dermatology care in urban and rural US populations
- Toral Vaidya, Lindsey Zubritsky, Ali Alikhan, Anne Housholder
- Differences between recruitment advertisements for academic and private practice dermatologists
- Kishore L. Jayakumar, Jules B. Lipoff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?